Co-diagnostics股票讨论区

$Co-diagnostics(CODX.US)$2017年上市后直到2020年开始有0.75亿的营收，2021年增长到0.98亿，但是2022年大幅下滑65%至0.34亿。营业利润则在2020和2021年分别盈利0.42亿和0.46亿，其余3年小幅亏损。净利润和营业利润类似。
2023Q1营收下滑97.4%，营业利润和净利润不出所料的继续亏损。
目前看营收波动非常大，利润可预测性很差，不过资产负债表非常稳健。
现金达到7530万，总负债只有637万，现金减去总负债有6890万，而目前市值仅有3330万。但是这个折扣和亏损比起来还是太少，如果继续亏损1年就可以亏完，目前缺乏吸引力。

Gainers:
In reaction to earnings/guidance:
• $梯瓦制药(TEVA.US)$ +24%(also announces agreement for opioids settlement), $Enphase Energy(ENPH.US)$ +9.5%, $Spotify Technology(SPOT.US)$ +9.2%, $RPC Inc(RES.US)$ +8.5%, $奇波雷墨西哥烧烤(CMG.US)$ +8.2%, $Manhattan Associates(MANH.US)$ +8.1%, $希尔顿酒店(HLT.US)$ +6.7%, $ChampionX(CHX.US)$ +6.1%, $Mr. Cooper Group(COOP.US)$ +5.7%, $Constellium(CSTM.US)$ +5.5%, $波士顿科学(BSX.US)$ +5.4%,...

Top positions heading into tomorrow :
$Co-diagnostics(CODX.US)$- Covid play
$Exela Technologies(XELA.US)$- all time low bounce play
$Express(EXPR.US)$- value play + 52 week low
$福特汽车(F.US)$- longer term swing / good value

$Co-diagnostics(CODX.US)$ last time I sold this it was over 20 👀

Wednesday, December 29, 2021
By Danilo
$梅思恩(MEOH.US)$ $阿克迈(AKAM.US)$ $Brooklyn ImmunoTherapeutics(BTX.US)$ $Nurix Therapeutics(NRIX.US)$ $Pear Therapeutics(PEAR.US)$ $Wingstop(WING.US)$ $Co-diagnostics(CODX.US)$

$Co-diagnostics(CODX.US)$ what is the target?

$CODX - STOCK & OPTION PLAY
FIRST SIGNED OF MORE UPTREND: $10.74
NEED IT TO BREAK OVER: $11.12
key indicator for MORE uptrend $11.27
confirmation uptrend - $11.59
mini breakout - $11.93
full breakout - $12.28
SEMI PARABOLIC - $12.84
stop loss — $10.54
& support - $10.25. $Co-diagnostics(CODX.US)$

$Co-diagnostics(CODX.US)$ stock has very low PE..

ER associated with the daily list
$Co-diagnostics(CODX.US)$ $AeroCentury Corp(ACY.US)$ $Biolase(BIOL.US)$